Home Services Spravato Therapy

Spravato® Esketamine Nasal Spray For Depression Treatment

Spravato® nasal spray is the groundbreaking FDA-approved medication for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.

Spravato® Esketamine Therapy

Good Health Psychiatric Services is at the forefront of offering innovative therapeutic options for challenging mental health conditions. We are proud to introduce Spravato®, the only FDA-approved nasal spray specifically formulated to treat adults with treatment-resistant depression (TRD) and depressive symptoms in adults with Major Depressive Disorder (MDD) with suicidal thoughts or actions.

Spravato® is administered as a nasal spray, allowing for direct absorption into the bloodstream. Its active ingredient, esketamine, is thought to influence neurotransmitters in the brain linked to mood and behavior. The nasal delivery system is designed to offer a swift onset of action, potentially bringing relief faster than conventional oral antidepressants.

Benefits of Spravato® Esketamine Spray

Treatment Process with Spravato® Esketamine at Good Health Psychiatric Services

Understanding the key stages of Spravato® therapy helps in managing mental health effectively. From the initial assessment to long-term support, each step is tailored to individual needs for the best possible outcome.

Initial Evaluation

Your journey begins with a comprehensive assessment by our experienced healthcare team. During this evaluation, we take the time to review your medical history, current symptoms, and treatment goals. This thorough understanding allows us to determine if Spravato® is a suitable treatment option for you.

01

Personalized Treatment Plan

Once the evaluation is complete, we collaborate to create a personalized treatment plan designed specifically for you. The plan considers factors such as the severity of your symptoms, previous treatment experiences, and any co-existing medical conditions. This individualized approach helps optimize the effectiveness and safety of the therapy.

02

Clinical Supervision and Support

Throughout your Spravato® treatment, you will receive dedicated care and support from our compassionate healthcare team. Our clinicians are trained to closely monitor your response to the therapy and provide ongoing supervision. We are always available to address any questions or concerns, ensuring you feel supported every step of the way.

03

Ongoing Monitoring and Adjustments

As you progress with Spravato® therapy, we conduct regular assessments to monitor your response and adjust your treatment plan as necessary. Your feedback and experiences are key in helping us ensure that the therapy continues to meet your evolving needs.

04

Ongoing Safety and Side Effects Monitoring

Due to its potential for sedation and dissociation, patients are closely monitored by healthcare professionals for at least two hours after taking Spravato®. The treatment is available only through a restricted program under the Spravato® Risk Evaluation and Mitigation Strategy (REMS) to ensure patient safety and compliance.

Serious side effects of Spravato® can include sedation, dissociation, increased blood pressure, and, in rare cases, respiratory depression. Patients with a history of substance misuse or certain cardiovascular or cerebrovascular conditions should discuss the risks with their healthcare provider. Because of the possibility of increased suicidal thoughts, vigilance in monitoring mood and behavior is critical.

Spravato® is not suitable for everyone. Patients must undergo a comprehensive assessment to determine eligibility. Close follow-up care is vital to track progress and response to the treatment.

What Clients said about us

4.6 / 5

We accept All major medical insurances

At Good Health Psychiatric Services, we understand the importance of receiving quality psychiatric and psychotherapy treatment for your well-being. As a leading mental health facility in Brooklyn, NY, we are committed to delivering the care you need in a way that’s accessible and convenient. We accept a wide range of insurance plans, including Aetna, Cigna, Oxford, United Healthcare, Anthem, and more, ensuring our comprehensive psychiatry services are covered.

cigna oscar aetna united healthcare healthfirst umr fidelis care bluecross blueshield
anthem metroplus multiplan optum healthplus medicare empire oxford 1199seiu

What to Expect After Treatment

After receiving Spravato® treatment, it’s important for patients to understand the post-treatment expectations. Patients may experience an improvement in their depressive symptoms, with some reporting changes as early as two days after the first dose. However, individual responses can vary.

In the days following treatment, patients should keep close communication with their healthcare provider, especially if new symptoms arise or if there’s a change in mood, behavior, or thoughts. Regular follow-up appointments are essential to assess the effectiveness of the treatment and to determine the need for further sessions.

If you’re considering Spravato® therapy, contact Good Health Psychiatric Services Clinic today to schedule an assessment. Our experienced professionals are here to guide you every step of the way—from the initial consultation to ongoing care and support.